Zobrazeno 1 - 10
of 276
pro vyhledávání: '"C, Padmapriyadarsini"'
Autor:
S. Ramesh Kumar, Chandrasekaran Kandhasamy, V. Banurekha Velayutham, Ponnuraja Chinnaiyan, Muthuramalingam Kannan, M. S. Jawahar, C. Padmapriyadarsini
Publikováno v:
Indian Journal of Public Health, Vol 68, Iss 3, Pp 362-365 (2024)
Background: Tuberculosis (TB) management continues to be a challenge globally; weakened immunity plays a significant role in the reactivation of TB. There is limited information on hematological parameters in patients with pulmonary TB and its associ
Externí odkaz:
https://doaj.org/article/1518c5892d594fc680ee9cf0cc8e3986
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 1, Pp 172-174 (2024)
Tuberculosis (TB) continues to be a global challenge. Reducing the duration of TB treatment for drug-sensitive TB (DSTB) has direct and distinct advantages. We ventured into the aspect of utilizing linezolid as a pivotal drug in shortening therapy in
Externí odkaz:
https://doaj.org/article/fcb7423b0a5f4c7b8ef7d1140331e6c2
Autor:
Hemant Deepak Shewade, Asha Frederick, Madhanraj Kalyanasundaram, Joshua Chadwick, G. Kiruthika, T. Daniel Rajasekar, K. Gayathri, R. Vijayaprabha, R. Sabarinathan, Shri Vijay Bala Yogendra Shivakumar, Kathiresan Jeyashree, P. K. Bhavani, S. Aarthi, K. V. Suma, Delphina Peter Pathinathan, Raghavan Parthasarathy, M. Bhavani Nivetha, Jerome G. Thampi, Deiveegan Chidambaram, Tarun Bhatnagar, S. Lokesh, Shanmugasundaram Devika, Timothy S. Laux, Stalin Viswanathan, R. Sridhar, K. Krishnamoorthy, M. Sakthivel, S. Karunakaran, S. Rajkumar, M. Ramachandran, K. D. Kanagaraj, M. Kaleeswari, V. P. Durai, R. Saravanan, A. Sugantha, S. Zufire Hassan Mohamed Khan, P. Sangeetha, R. Vasudevan, R. Nedunchezhian, M. Sankari, N. Jeevanandam, S. Ganapathy, V. Rajasekaran, T. Mathavi, A. R. Rajaprakash, Lakshmi Murali, U. Pugal, K. Sundaralingam, S. Savithri, S. Vellasamy, D. Dheenadayal, P. Ashok, K. Jayasree, R. Sudhakar, K. P. Rajan, N. Tharageshwari, D. Chokkalingam, S. M. Anandrajkumar, T. S. Selvavinayagam, C. Padmapriyadarsini, Ranjani Ramachandran, Manoj V. Murhekar
Publikováno v:
Global Health Action, Vol 16, Iss 1 (2023)
Due to the workload and lack of a critical mass of trained operational researchers within their ranks, health systems and programmes may not be able to dedicate sufficient time to conducting operational research (OR). Hence, they may need the technic
Externí odkaz:
https://doaj.org/article/0c8d9c29b3f9428ba9604d15789727e3
Autor:
Devaleenal Daniel, Bella, Baskaran, Abinaya, D, Baskaran, Mercy, Hephzibah, C, Padmapriyadarsini
Publikováno v:
In Indian Journal of Tuberculosis October 2023 70(4):460-467
Autor:
Constantino Lopes, Debashish Kundu, Ismael Da Costa Barreto, Bernardino da Cruz, S. Siva Kumar, Sureshbabu Ramalingam, Anna S. Dean, Vineet Bhatia, Prabhu Seenivasan, C. Padmapriyadarsini, Olga Tosas Auguet
Publikováno v:
Global Health Research and Policy, Vol 7, Iss 1, Pp 1-9 (2022)
Abstract Background A national drug resistance survey (DRS) was implemented for the first time in Timor-Leste (TL) in 2019. The primary objective of the survey was to assess the prevalence of drug resistance among new and previously treated pulmonary
Externí odkaz:
https://doaj.org/article/e110a4f4f1c547018ac4fab02dcc9e18
Autor:
Nathella Pavan Kumar, V. V. Banurekha, Girish Kumar C. P., Arul Nancy, C. Padmapriyadarsini, A. Stella Mary, K. R. Uma Devi, Manoj Murhekar, Subash Babu
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Covaxin/BBV152 is a whole virion inactivated SARS-CoV-2 vaccine. The effect of prime-boost vaccination with Covaxin on systemic immune responses is not known. We investigated the effect of Covaxin on the plasma levels of a wide panel of cytokines and
Externí odkaz:
https://doaj.org/article/9ff851b346ce47b0a7017c1786ad5e55
Autor:
K. S. Sachdeva, A. K. Bhatnagar, A. Bhaskar, N. Singla, R. Sridhar, B. Ramraj, A. Athawale, R. Solanki, S. R. Baruah, Y. Patel, R. Ramachandran, C. Padmapriyadarsini
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 27:329-331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f41578dfb6e5bb7012707b0c0a3d404
https://doi.org/10.5588/ijtld.22.0406
https://doi.org/10.5588/ijtld.22.0406
Autor:
B, Velayutham, V, Shah, V, Mythily, R, Gopalaswamy, N, Kumar, S, Mandal, M, Parmar, C, Padmapriyadarsini
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 26:1033-1040
INTRODUCTION: Patients with isoniazid (H, INH) resistant pulmonary TB but undetected rifampicin (R, RIF) resistance are treated with a 6-month regimen of levofloxacin-RIF-ethambutol-pyrazinamide (6LvxREZ) under India´s National TB Elimination Progra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c95e1275379252171727d0ff1d716ee
https://doi.org/10.5588/ijtld.21.0701
https://doi.org/10.5588/ijtld.21.0701
Publikováno v:
Indian Journal of Tuberculosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64cc4cbf05b40021ef451f85c313248b
https://doi.org/10.1016/j.ijtb.2023.03.022
https://doi.org/10.1016/j.ijtb.2023.03.022
Publikováno v:
Indian Journal of Tuberculosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f85e4888e3ee242729bb1620a358accb
https://doi.org/10.1016/j.ijtb.2023.04.019
https://doi.org/10.1016/j.ijtb.2023.04.019